Krzysztof Sladek: Influence Statistics

Krzysztof Sladek: Expert Impact

Concepts for which Krzysztof Sladek has direct influence: Nintedanib patients , Patients nintedanib , Idiopathic pulmonary fibrosis , Nintedanib placebo , Manidipine amlodipine , Pulmonary fibrosis , Placebo rate .

Krzysztof Sladek: KOL impact

Concepts related to the work of other authors for which for which Krzysztof Sladek has influence: Idiopathic pulmonary fibrosis , 55 years , Nintedanib patients , Progressive phenotype , Hub genes , Fvc decline , Lung fibroblasts .

KOL Resume for Krzysztof Sladek


Outpatient Clinic, Krakow, Poland

Prominent publications by Krzysztof Sladek

KOL-Index: 17065 . BACKGROUND: A hallmark of idiopathic pulmonary fibrosis is the excess accumulation of extracellular matrix in the lungs. Degradation of extracellular matrix generates free-circulating protein fragments called neoepitopes. The aim of the INMARK trial was to investigate changes in neoepitopes as predictors of disease progression in patients with idiopathic pulmonary fibrosis and the effect ...
Known for Nintedanib Patients | Pulmonary Fibrosis | Extracellular Matrix | 12 Weeks
KOL-Index: 7760 . Background and objective: Isolated systolic hypertension (ISH) affects 10–20% of the elderly population and is strongly related to the risk of cardiovascular events. Elevated systolic BP values are primarily caused by reduced large vessel compliance with a consequent increase in total peripheral resistance. Vasodilating drugs, such as calcium channel antagonists, have proven to be ...
Known for Manidipine Amlodipine | Mm Hg | Calcium Channel | Efficacy Safety

Key People For Nintedanib Patients

Top KOLs in the world
Ganesh R Raghu
idiopathic pulmonary fibrosis interstitial lung disease patients ipf
Andrew Gordon Nicholson
lung cancer idiopathic pulmonary fibrosis interstitial pneumonia
David M Hansell
computed tomography idiopathic pulmonary fibrosis lung cancer
Ulrich Costabel
idiopathic pulmonary fibrosis bronchoalveolar lavage hypersensitivity pneumonitis
Luca Richeldi
idiopathic pulmonary fibrosis inpulsis trials patients ipf
Susanne Stowasser
idiopathic pulmonary fibrosis nintedanib patients inpulsis trials
Similar searches    nintedanib patients

Outpatient Clinic, Krakow, Poland